We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Stephen Wu McDermott Will & Emery

Results 1 to 5 of 14

FTC hosts public workshop, “Examining Health Care Competition” *

USA - March 25 2014
During the last several years, the Federal Trade Commission (FTC) has taken an active role in antitrust enforcement in the health care industry…

Co-authors: Joseph F. Winterscheid, Jeffrey W. Brennan, James Buchanan Camden.

FTC reaches unique settlement with phoebe Putney Health System resolving lengthy hospital merger challenge *

USA - August 26 2013
The U.S. Federal Trade Commission (FTC) and Phoebe Putney Health System settled the FTC's complaint that the health system's merger with Palmyra Park…

Co-authors: Carrie G. Amezcua.

Supreme Court limits availability of state action immunity from federal antitrust liability *

USA - February 20 2013
The Supreme Court decision in FTC v. Phoebe Putney Health System, Inc., makes clear that state action immunity from federal antitrust laws is…

Co-authors: David Marx Jr., Jeffrey W. Brennan, Christine G. Devlin, Ashley McKinney Fischer.

DOJ issues business review letter regarding hospital-physician gainsharing program *

USA - January 22 2013
On January 16, the U.S. Department of Justice Antitrust Division issued a Business Review Letter in which it disclosed its intention not to challenge…

Deputy director Dafny: FTC focuses on diversion ratios, not geographic markets for hospital mergers *

USA - October 4 2012
During an American Bar Association (ABA) program on antitrust and health care issues on October 1, 2012, U.S. Federal Trade Commission (FTC) Deputy Director for Health Care and Antitrust, Leemore Dafny, said that the FTC will focus on how patients purportedly react to price increases, as measured by "diversion ratios," when deciding which hospital mergers to investigate further for potential anticompetitive effects.

Next »